Division of Pediatric Endocrinology, Department of Pediatrics, Faculty of Medicine, Kirikkale University, Kirikkale, Turkey.
Department of Nutrition and Dietetics, Kirikkale University Faculty of Health Sciences, Kirikkale, Turkey.
Int J Clin Pract. 2020 Sep;74(9):e13554. doi: 10.1111/ijcp.13554. Epub 2020 Jun 8.
It's known that overt hypothyroidism increases body fat content and weight. There's limited research about the effect of subclinical hypothyroidism (SH) on body composition in children and the effect of LT4 treatment. We aimed to evaluate body composition parameters in healthy subjects and in children with mild SH (MSH) and determine the effect of LT4 treatment.
Sixty-four healthy children and 32 children with MSH were included. Anthropometric measurements and hormonal parameters were evaluated. Body composition was evaluated using bioelectric impedance analysis (BIA). Patients were put on LT4 treatment. BIA was performed again after 12 months of therapy.
There was no significant difference between the anthropometric parameters and basal metabolic rate of the healthy children and the MSH group. The percentage of trunk muscle mass (TMM) in the MSH group was lower than in the control group (P < .05). After 12 months of LT4 treatment, the percentage of total fat-free mass (FFM), TMM and trunk fat-free mass (TFFM) were increased and percentage of total body fat mass and trunk fat mass were decreased (P < .05). The difference between the percentage of TMM in the MSH group and control group was insignificant after LT4 treatment (P > .05).
The percentage of TMM in children with MSH was found lower than healthy control group. After LT4 treatment, the percentage of the FFM, TMM and TFFM were increased and the difference between percentage of TMM in children with MSH and healthy controls was insignificant. Our data indicated that MSH might be associated with early changes in body composition parameters.
众所周知,显性甲状腺功能减退症会增加体脂肪含量和体重。关于亚临床甲状腺功能减退症(SH)对儿童身体成分的影响以及 LT4 治疗的影响,研究有限。我们旨在评估健康受试者和轻度 SH(MSH)儿童的身体成分参数,并确定 LT4 治疗的效果。
纳入 64 名健康儿童和 32 名 MSH 儿童。评估了人体测量学和激素参数。使用生物电阻抗分析(BIA)评估身体成分。患者接受 LT4 治疗。治疗 12 个月后再次进行 BIA。
健康儿童和 MSH 组的人体测量参数和基础代谢率无显著差异。MSH 组的躯干肌肉质量(TMM)百分比低于对照组(P <.05)。LT4 治疗 12 个月后,总去脂体重(FFM)、TMM 和躯干去脂体重(TFFM)的百分比增加,而总体脂肪量和躯干脂肪量的百分比降低(P <.05)。LT4 治疗后,MSH 组 TMM 百分比与对照组之间的差异无统计学意义(P >.05)。
MSH 儿童的 TMM 百分比低于健康对照组。LT4 治疗后,FFM、TMM 和 TFFM 的百分比增加,MSH 儿童与健康对照组 TMM 百分比的差异无统计学意义。我们的数据表明,MSH 可能与身体成分参数的早期变化有关。